Insider sale
KYMERA THERAPEUTICS, INC.
$9.45M
107.66K shares
What this filing means
ATLAS VENTURE FUND X, L.P. plans to sell 107.66K shares of KYMERA THERAPEUTICS, INC. valued at approximately $9.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/17/2026ACC: 0001628280-26-044011
10% Owner
Since Aug 2020
107.66K
Shares to sell
$9.45M
Approx. market value
92.17K
Acquired (3 months)
1
Planned
7 completed
Securities Acquired — Last 3 Months1
Private Placement
Cash
3/11/2020
92.17KTotal acquired92.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/11/2020 | Private Placement Cash | 92.17K | — |
| Total | 92.17K | ||
Planned & Completed Dispositions8
Completed
—Completed
Units to sell
5.90K
Market value
$530.7K
4/22/2026
—Completed
Units to sell
88.00
Market value
$7.9K
4/22/2026
—Completed
Units to sell
12.00
Market value
$1.1K
4/22/2026
—Completed
Units to sell
2.20K
Market value
$197.9K
4/15/2026
—Completed
Units to sell
2.75K
Market value
$247.8K
4/15/2026
—Completed
Units to sell
385.00
Market value
$34.7K
4/15/2026
—Completed
Units to sell
4.16K
Market value
$374.2K
4/14/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
92.17K
Market value
$8.06M
6/17/2026
Total
Units
107.66K
Value
$9.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/22/2026 | 5.90K | $530.7K | — | Completed |
4/22/2026 | 88.00 | $7.9K | — | Completed |
4/22/2026 | 12.00 | $1.1K | — | Completed |
4/15/2026 | 2.20K | $197.9K | — | Completed |
4/15/2026 | 2.75K | $247.8K | — | Completed |
4/15/2026 | 385.00 | $34.7K | — | Completed |
4/14/2026 | 4.16K | $374.2K | — | Completed |
| Planned — Approximate Date | ||||
6/17/2026 | 92.17K | $8.06M | Nasdaq | Planned |
| Total | 107.66K | $9.45M | ||